Ex Parte Gartstein et al - Page 10


               Appeal No. 2005-1117                                                                                                  
               Application 10/078,043                                                                                                

               of the evidence of anticipation found in Eckhouse with appellants’ countervailing arguments for                       
               non-anticipation in the brief, and based thereon, conclude that the claimed invention                                 
               encompassed by appealed claims 1 through 13 would have been anticipated as a matter of fact                           
               under § 102(b).                                                                                                       
                       Our review of the record on this appeal further leads us to agree with the supported                          
               position advanced by the examiner that, prima facie, the claimed method for achieving the                             
               meaningful suppression of the growth potential of a pathogen in a living organism encompassed                         
               by appealed claim 10 would have been obvious over the combined teachings of Eckhouse and                              
               Talmore to one of ordinary skill in this art at the time the claimed invention was made.  In view                     
               of the established prima facie case of obviousness, we again consider the record as a whole with                      
               respect to this ground of rejection in light of appellants’ rebuttal arguments in the brief.  See                     
               generally, In re Oetiker, 977 F.2d 1443, 1445, 24 USPQ2d 1443, 1444 (Fed. Cir. 1992); In re                           
               Piasecki, 745 F.2d 1468, 1472, 223 USPQ 785, 788 (Fed. Cir. 1984).                                                    
                       We determine that in giving the language thereof the broadest reasonable interpretation in                    
               light of the specification, claim 10 specifies a method comprising at least “applying a broad-                        
               spectrum electromagnetic radiation from an apparatus according to Claim 11” to the locus of any                       
               pathogen in any organism to achieve meaningful suppression of the growth potential of that                            
               pathogen.  Thus, the apparatus to be employed in the claimed method is defined in claim 11                            
               which we have interpreted above.  See Morris, supra; Zletz, supra.                                                    
                       Appellants submit that Eckhouse does not disclose the apparatus and that Talmore “fails                       
               to teach or suggest the claim limitations which distinguish the claimed invention of claim 11                         
               over” Eckhouse (brief, page 7).  Appellants admit that Talmore “may teach some of the claim                           
               limitations that [Eckhouse] is lacking, i.e., the treatment of pathogens and fungi” (id.).  The                       
               examiner responds that “Talmore was cited as a teaching of specifically treating skin pathogens                       
               with light energy,” with the combined teachings suggesting that Eckhouse’s apparatus would                            
               “inherently treat any pathogens located on the tissue” (answer, pages 6-7).                                           
                       We find no argument by appellants with respect to claim 10 which further addresses                            
               whether Eckhouse’s handheld flashlamp satisfies all of the limitations of claim 11, and thus, on                      
               this record, we are in agreement with the examiner’s position in the here considered ground of                        
               rejection.  We are reinforced in our view by our finding above of the disclosure of the treatment                     

                                                               - 10 -                                                                



Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007